RAYMOND JAMES & ASSOCIATES - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$204,875
-58.1%
3,742
-35.7%
0.00%
Q2 2023$488,848
-68.2%
5,821
-71.3%
0.00%
-100.0%
Q1 2023$1,535,653
+246.3%
20,278
+182.3%
0.00%
Q4 2022$443,396
+94.5%
7,184
+31.2%
0.00%
Q3 2022$228,000
-36.1%
5,474
-36.3%
0.00%
Q1 2021$357,0008,5950.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sandhill Capital Partners LLC 1,805,518$34,594,0002.69%
Millrace Asset Group, Inc. 83,723$1,604,0000.94%
Bullseye Asset Management LLC 117,031$2,218,0000.88%
Taylor Wealth Management Partners 72,782$1,395,0000.49%
MOODY ALDRICH PARTNERS LLC 166,078$3,182,0000.44%
HARBOURVEST PARTNERS LLC 116,123$2,225,0000.28%
NEXT CENTURY GROWTH INVESTORS LLC 161,819$3,100,0000.28%
EMERALD MUTUAL FUND ADVISERS TRUST 300,492$5,757,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 82,255$1,576,0000.18%
EMERALD ADVISERS, LLC 244,816$4,691,0000.17%
View complete list of TRANSMEDICS GROUP INC shareholders